Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
0 hedge funds and large institutions have $0 invested in Inari Medical, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.
100% less funds holding
Funds holding: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $398K → $0 (-$398K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SA
SoundView Advisors
Olympia,
Washington
|
-$250K |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
-$141K |
| 3 |
TCWM
Total Clarity Wealth Management
St. Charles,
Illinois
|
-$4.08K |
| 4 |
PS
Principal Securities
Des Moines,
Iowa
|
-$3.11K |
NARI Hedge Fund Activity: Q2 2025 in Review
0 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q2 2025, worth a combined $0 — down 100% from $398K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NARI and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was SoundView Advisors, exiting entirely with an estimated $250K sold.
- 0 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q2 2025, down from 4 in Q1 2025.
- Funds reported $0 of Inari Medical, Inc. Common Stock stock for Q2 2025, down 100% quarter-over-quarter.
- 0 funds opened new Inari Medical, Inc. Common Stock positions in Q2 2025 and 4 closed out, a net change of -4 holders.
- The largest Inari Medical, Inc. Common Stock seller in Q2 2025 was SoundView Advisors, an estimated $250K sold.
Based on aggregated 13F filings for Q2 2025.